shutterstock_1436567156_jonathan_weiss
Jonathan Weiss / Shutterstock.com
27 August 2019Big PharmaSaman Javed

Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
6 February 2019   A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
Big Pharma
6 November 2019   German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.

More on this story

Americas
6 February 2019   A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
Big Pharma
6 November 2019   German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.

More on this story

Americas
6 February 2019   A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.
Big Pharma
6 November 2019   German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.